These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 23548715)

  • 1. Recent advances in research of HIV infection: implications of viral and host genetics on treatment and prevention.
    Haaland RE; Johnson JA; Tang J
    Public Health Genomics; 2013; 16(1-2):31-6. PubMed ID: 23548715
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Estimating the Respective Contributions of Human and Viral Genetic Variation to HIV Control.
    Bartha I; McLaren PJ; Brumme C; Harrigan R; Telenti A; Fellay J
    PLoS Comput Biol; 2017 Feb; 13(2):e1005339. PubMed ID: 28182649
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HIV Maintains an Evolving and Dispersed Population in Multiple Tissues during Suppressive Combined Antiretroviral Therapy in Individuals with Cancer.
    Rose R; Lamers SL; Nolan DJ; Maidji E; Faria NR; Pybus OG; Dollar JJ; Maruniak SA; McAvoy AC; Salemi M; Stoddart CA; Singer EJ; McGrath MS
    J Virol; 2016 Oct; 90(20):8984-93. PubMed ID: 27466425
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HIV testing and antiretroviral treatment strategies for prevention of HIV infection: impact on antiretroviral drug resistance.
    Nichols BE; Boucher CA; van de Vijver DA
    J Intern Med; 2011 Dec; 270(6):532-49. PubMed ID: 21929723
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Viral sequence analysis from HIV-infected mothers and infants: molecular evolution, diversity, and risk factors for mother-to-child transmission.
    Bulterys PL; Dalai SC; Katzenstein DA
    Clin Perinatol; 2010 Dec; 37(4):739-50, viii. PubMed ID: 21078447
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The challenges of host and viral diversity in HIV vaccine design.
    Brander C; Frahm N; Walker BD
    Curr Opin Immunol; 2006 Aug; 18(4):430-7. PubMed ID: 16777397
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of genotypic resistance to antiretroviral drugs in treatment-naive youths infected with diverse HIV type 1 subtypes and recombinant forms in Dar es Salaam, Tanzania.
    Mosha F; Urassa W; Aboud S; Lyamuya E; Sandstrom E; Bredell H; Williamson C
    AIDS Res Hum Retroviruses; 2011 Apr; 27(4):377-82. PubMed ID: 20954839
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lessons from acute HIV infection.
    Robb ML; Ananworanich J
    Curr Opin HIV AIDS; 2016 Nov; 11(6):555-560. PubMed ID: 27716734
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular biological assessment methods and understanding the course of the HIV infection.
    Katzenstein TL
    APMIS Suppl; 2003; (114):1-37. PubMed ID: 14626050
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human immunodeficiency virus type 1 genetic diversity in the nervous system: evolutionary epiphenomenon or disease determinant?
    van Marle G; Power C
    J Neurovirol; 2005 Apr; 11(2):107-28. PubMed ID: 16036790
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Weaker HLA Footprints on HIV in the Unique and Highly Genetically Admixed Host Population of Mexico.
    Soto-Nava M; Avila-Ríos S; Valenzuela-Ponce H; García-Morales C; Carlson JM; Tapia-Trejo D; Garrido-Rodriguez D; Alva-Hernández SN; García-Tellez TA; Murakami-Ogasawara A; ; Mallal SA; John M; Brockman MA; Brumme CJ; Brumme ZL; Reyes-Teran G;
    J Virol; 2018 Jan; 92(2):. PubMed ID: 29093100
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HIV sequence diversity during the early phase of infection is associated with HIV DNA reductions during antiretroviral therapy.
    Wang N; Li Y; Han Y; Xie J; Li T
    J Med Virol; 2017 Jun; 89(6):982-988. PubMed ID: 27791274
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High Prevalence of Drug Resistance Mutations Among Patients Failing First-Line Antiretroviral Therapy and Predictors of Virological Response 24 Weeks After Switch to Second-Line Therapy in São Paulo State, Brazil.
    Matsuda EM; Coelho LPO; Romero GF; de Moraes MJ; Lopez-Lopes GIS; Morejon K; Campeas AE; Cabral GB; Brígido LFM
    AIDS Res Hum Retroviruses; 2018 Feb; 34(2):156-164. PubMed ID: 28969448
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical development of microbicides for the prevention of HIV infection.
    D'Cruz OJ; Uckun FM
    Curr Pharm Des; 2004; 10(3):315-36. PubMed ID: 14754390
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Viro-immunological response and emergence of resistance in HIV-infected women receiving combination antiretroviral regimens for the prevention of mother-to-child transmission in Malawi.
    Palombi L; Galluzzo CM; Pirillo MF; Liotta G; Andreotti M; Jere H; Sagno JB; Luhanga R; Mancinelli S; Ceffa S; Amici R; Marazzi MC; Vella S; Giuliano M
    J Antimicrob Chemother; 2014 Mar; 69(3):749-52. PubMed ID: 24135952
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic diversity of HIV in Africa: impact on diagnosis, treatment, vaccine development and trials.
    Peeters M; Toure-Kane C; Nkengasong JN
    AIDS; 2003 Dec; 17(18):2547-60. PubMed ID: 14685049
    [No Abstract]   [Full Text] [Related]  

  • 17. Beyond first-line HIV treatment regimens: the current state of antiretroviral regimens, viral load monitoring, and resistance testing in resource-limited settings.
    Kumarasamy N; Krishnan S
    Curr Opin HIV AIDS; 2013 Nov; 8(6):586-90. PubMed ID: 24100872
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence that low-level viremias during effective highly active antiretroviral therapy result from two processes: expression of archival virus and replication of virus.
    Tobin NH; Learn GH; Holte SE; Wang Y; Melvin AJ; McKernan JL; Pawluk DM; Mohan KM; Lewis PF; Mullins JI; Frenkel LM
    J Virol; 2005 Aug; 79(15):9625-34. PubMed ID: 16014925
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of primary drug resistance on CD4+ cell decline and the viral load set-point in HIV-positive individuals before the start of antiretroviral therapy.
    Schultze A; Torti C; Cozzi-Lepri A; Vandamme AM; Zazzi M; Sambatakou H; De Luca A; Geretti AM; Sonnerborg A; Ruiz L; Monno L; Di Giambenedetto S; Gori A; Lapadula G;
    AIDS; 2019 Feb; 33(2):315-326. PubMed ID: 30325769
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.